DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Aapro M, Schwartzberg L.
Efficacy of intravenous (IV) NEPA and oral NEPA, fixed NK1/5-HT3 receptor antagonist combination agents, for prevention of chemotherapy-induced nausea and vomiting (CINV) following anthracycline-cyclophosphamide (AC)-based chemotherapy.
San Antonio Breast Cancer Symposium 2019; P2-12-04
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.